SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic

Autor: Zely Arivelo Randriamanantany, Paquerette Hanitriniala Sahondranirina, Matthieu Schoenhals, Manuela Christophère Vololoniaina, Niry Rabenindrina, Soa Fy Andriamandimby, Jean-Michel Heraud, Voahangy Rasolofo, Philippe Dussart, Fidiniana Mamy Randriatsarafara, Rindra Randremanana, Jean Marius Rakotondramanga, André Spiegel
Přispěvatelé: Institut Pasteur de Madagascar, Réseau International des Instituts Pasteur (RIIP), Ministère de la Santé Publique [Antananarivo, Madagascar], This project was funded by the United States Agency for International Development.
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: EBioMedicine
EBioMedicine, Elsevier, 2021, 68, pp.103419. ⟨10.1016/j.ebiom.2021.103419⟩
EBioMedicine, Vol 68, Iss, Pp 103419-(2021)
ISSN: 2352-3964
Popis: We thank the blood donors and RBTC staff who supported this work, importantly Drs Jocelyne Nirina ANDRIAMBELO (RBTC Toamasina), Léa Isabelle RAMANDIMBISOA (RBTC Toliara), Michael Marie Osé HARIOLY NIRINA (NRTC Antananarivo), Dr Danielle FITAHIANA (RBTC Fianarantsoa) and Pr Tahiry RABENANDRIANINA (RBTC Mahajanga).We thank the Immunology of Infectious Diseases unit staff for performing assays, as well as the 4 laboratories in Madagascar where RT-PCRs were run particularly the IPM virology unit.We express our gratitude to the National Institute of Statistics of Madagascar and its Director General Isaora Zefania ROMALAHY, for sharing with us the 2020 demographics of Madagascar; International audience; Background: The incidence of the 2020 COVID-19 epidemic in Africa seems to be different from that of the rest of the world, however its true extent is probably underestimated. Conducting population based sero-surveys during the epidemic has moreover been extremely challenging, driving our group and others to study blood donor samples.Methods: We collected regional epidemiological COVID-19 surveillance data, and simultaneously monitored anti-SARS-CoV-2 antibody seroprevalences monthly throughout the epidemic in 5 major Region-associated Blood Transfusion Centres of Madagascar over a period of 9 months.Findings: Soon after attaining the first epidemic peaks between May and August 2020, both crude and population-weighted test-performance-adjusted seroprevalences of anti-SARS-CoV-2 antibodies was in Malagasy blood donors rapidly increased up to over 40% positivity.Interpretation: These findings suggest a high cumulative incidence of infection and seroconversion, which may have contributed to the observed deceleration of infection rates, but was not sufficient to prevent the second epidemic wave that struck Madagascar in Spring 2021.
Databáze: OpenAIRE